Akademik Veri Yönetim Sistemi
9th International ACHARAKA Medicine Nursing Midwifery and Health Sciences Congress , Baku, Azerbaycan, 12 - 16 Aralık 2024, ss.1393-1420, (Tam Metin Bildiri)
ntroduction: This study was conducted to evaluate the current technologies used in the management of Type-1 Diabetes by bibliometric analysis. Method: Web of Science database was searched and 2496 publications on the subject published between 2020-2024 were analysed. Using VOSviewer 1.6.20 software for bibliometric analysis, author, country, institutional collaborations and keyword association networks were examined, citation and co-citation analyses were performed, and the data were visualised by scientific mapping method. Results: The results show that continuous glucose monitoring (CGM) systems, artificial pancreas and artificial intelligence applications are becoming increasingly prominent in the management of Type-1 DM. In the keyword analysis by year, it was observed that pandemic-related terms such as ‘telemedicine’ and ‘lockdown’ were used more frequently in the 2020-2021 period, while technological developments such as ‘continuous glucose monitoring’, ‘artificial pancreas’ and ‘glycemic control’ were focused on in 2022 and beyond. In 2023 and beyond, it was observed that innovative approaches such as ‘machine learning’, ‘real world evidence’ and ‘advanced hybrid closed-loop system’ were studied. This situation reveals that individualised and more precise glycaemic control targets are adopted in diabetes management. Most of the research is concentrated in countries such as the USA, the UK and Germany, with Stanford University, the University of Colorado and Harvard Medical School being the institutions with the highest connectivity. While the studies emphasise the importance of collaboration in the development of technologies used in the management of Type-1 DM, they point to existing gaps in equal access and sustainability. Conclusion: Current technologies used in the management of type-1 DM have been reported to provide significant benefits in terms of improving patients' quality of life and improving glycaemic control. However, inequalities in access to these technologies are important issues that need to be addressed. The study may provide a valuable perspective to identify current trends in the field and provide guidance for future research.